Craig McCann named Neurocare Ambassador

Paralympic wheelchair fencer Craig McCann has been announced as an ambassador for Sheffield based charity Neurocare, which raises money for specialist equipment in the Hallamshire area, where he received treatment in 2004. Craig was diagnosed with a brain tumor, which was successfully removed, and thanks to the he received from all at the Royal Hallamshire Hospital he was able to make a full recovery.

McCann said ‘After having life-saving neurosurgery at the Hallamshire in 2004 I am completely thrilled to now be an ambassador for a charity so close to my heart’.

Due to his earlier surgery, Craig was left with nerve damage which resulted in limb weakness and problems with hearing and sight. Such was his passion for sport and using this to overcome his disability, Craig soon found himself having aspirations of representing Great Britain at the Paralympic Games. It was with these hopes in mind that Craig attended a Paralympics potential day run by Paralympics GB. Despite originally attending in the hope of catching the eye of the rowing team, it was the Wheelchair Fencing team who came away with a new potential athlete.

From being invited to train with the squad, Craig rapidly took to his new sport, and was soon representing Great Britain in domestic and international competitions. London 2012 was then Craig’s ambitious goal. Sure enough, a little over two years from first taking up the sport, Craig was selected for the seven strong GB squad at London 2012 in the wheelchair fencing team event. His rise through the ranks has been little short of meteoric, representing both his considerable talents and determination.

Craig also is an experienced speaker, and is an avid fan of all sports and a Chelsea and Grimsby Town football fan.

Neurocare provide the Royal Hallamshire hospital with vital equipment to help those requiring brain surgery. You can follow them on Facebook at https://en-gb.facebook.com/neurocare.charity.
Read More:

http://www.neurocare.org.uk/wp-content/uploads/2012/11/Neurocare-Newsletter-October-2012.pdf